Interim analysis of a single-arm, phase II study of bevacizumab (BV) with modified OPTIMOX1 as first-line treatment of patients with metastatic colorectal cancer (mCRC): TCOG-GI0802. Outcomes of ...

In the March issue of Diseases of the Colon & Rectum, surgeons from Australia discuss postoperative pain control following one of the most extensive operations performed for pelvic cancer. In an era ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Cervical cancer is one of the most common cancers in women worldwide. Annually, it is estimated that 493 000 women worldwide will be diagnosed with cervical carcinoma and that 273 000 will die from ...

IT has been established that removal of all the pelvic viscera can be accomplished with a mortality of 25 per cent or less and that the resultant physiologic readjustments permit a comfortable and ...